Company Details
|
|
Address
|
30 Quai Gustave Ador, Geneva, 1207
|
|
Telephone
|
|
|
Fax
|
|
Executives
|
|
Chairman
|
Adrian Collins (0.40% holding)
|
|
Chief Executive
|
Daniel Ishag* (19.40% holding)
|
|
Finance Director
|
(0.00% holding)
|
|
Director
|
William Moon (4.00% holding)
|
Main Shareholders
|
|
|
Connemara Services: 19.4%
Credit Agricole Cheuvreux Int: 9.7%
Adrian Harris: 6.8%
New Far East Associates: 6.5%
|
Advisers
|
|
Nominated Adviser
|
Strand Partners
|
|
Nominated Broker
|
Keith Bayley Rogers; Novus Capital
|
|
Solicitors
|
Fladgate
|
|
Auditors
|
Grant Thornton
|
|
Registrar
|
Computershare Investor Services
|
|
Commentary
|
|
Holding company of a group involved in the design and sale of an advanced biological solution to the treatment of wastewater, called HYBACS
|
Company Data |
| Code |
BWB |
| Sedol |
KYG1194910 |
| Shares In Issue |
248.019 m |
| Indices
|
|
| Entry on AIM |
13/12/2007 |
| Interim Results |
Mar |
| Final Results |
Sep |
| Year End |
Jun |
| Accounts Due |
n/a |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
|
| |
|
|
